Kinaplat 100mg Infusion
Prescription Required
Product introduction
Kinaplat 100mg Infusion is used in the treatment of cancer of colon and rectum. It shows its working by stopping or slowing down the growth of cancer cells.
Kinaplat 100mg Infusion is given as an injection into vein by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
Nausea, fatigue, vomiting, and diarrhea are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. It may cause some serious allergic reaction, inform your doctor if you notice sore lips or mouth ulcers, rash, itching and difficulty breathing. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.
Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It makes men infertile, hence men should take doctor advice about the freezing of sperm before the treatment. You must avoid driving after taking this medicine as it may cause dizziness.
Uses of Kinaplat Infusion
Side effects of Kinaplat Infusion
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Kinaplat
- Abdominal pain
- Injection site reaction
- Weight gain
- Conjunctivitis
- Fever
- Nosebleeds
- Hair loss
- Constipation
- Skin disorder
- Decreased appetite
- Infection
- Peripheral sensory neuropathy
- Inflammation of the nose
- Pain
- Increased transaminase level in blood
- Increased alkaline phosphatase level in blood
- Taste change
- Edema (swelling)
- Lacrimation disorder
- Allergic reaction
- Fatigue
- Nausea
- Vomiting
- Diarrhea
- Stomatitis (Inflammation of the mouth)
- Anemia (low number of red blood cells)
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Headache
- Breathlessness
How to use Kinaplat Infusion
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
How Kinaplat Infusion works
Kinaplat 100mg Infusion is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Kinaplat 100mg Infusion. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Kinaplat 100mg Infusion is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Kinaplat 100mg Infusion is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Kinaplat 100mg Infusion may cause side effects which could affect your ability to drive.
Kinaplat 100mg Infusion treatment may result in an increased risk of dizziness, nausea, and vomiting, and other neurological symptoms that affect walking and this may affect your ability to drive.
Kinaplat 100mg Infusion treatment may result in an increased risk of dizziness, nausea, and vomiting, and other neurological symptoms that affect walking and this may affect your ability to drive.
Kidney
CAUTION
Kinaplat 100mg Infusion should be used with caution in patients with severe kidney disease. Dose adjustment of Kinaplat 100mg Infusion may be needed. Please consult your doctor.
Limited information is available on the use of Kinaplat 100mg Infusion in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Limited information is available on the use of Kinaplat 100mg Infusion in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver
CAUTION
Kinaplat 100mg Infusion should be used with caution in patients with liver disease. Dose adjustment of Kinaplat 100mg Infusion may be needed. Please consult your doctor.
What if you forget to take Kinaplat Infusion?
If you miss a dose of Kinaplat 100mg Infusion, please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
Kinaplat 100mg Infusion
₹120.82/ml of Infusion
Oxaltor 100mg Infusion
Torrent Pharmaceuticals Ltd
₹53.1/ml of infusion
56% cheaper
Oxol 100mg Infusion
Venus Remedies Ltd
₹64.64/ml of infusion
46% cheaper
Oxichemo 100mg Infusion
Lupin Ltd
₹38.78/ml of infusion
68% cheaper
Oxitan 100mg Infusion
Fresenius Kabi India Pvt Ltd
₹98.36/ml of infusion
19% cheaper
Oxitan Infusion
Fresenius Kabi India Pvt Ltd
₹228/ml of infusion
89% costlier
Quick tips
- Kinaplat 100mg Infusion is given as an injection into veins under the supervision of a doctor.
- Kinaplat 100mg Infusion is given as an injection into veins under the supervision of a doctor.
Fact Box
Chemical Class
Platinum Analogs
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Platinum compounds-Anticancer
Interaction with drugs
Taking Kinaplat with any of the following medicines can modify the effect of either of them and cause some undesirable side effects
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 1 day before until 1 day after taking Sargramostim. P
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Lenograstim from 24 hours before until 24 hours after undergoing cytot
Concomitant use may affect heart rhythm.
Do not consume Oxaliplatin with Domperidone.
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 14 days before until 24 days after taking Pegfilgrast
Concurrent use may cause a decrease in the ability of the bone marrow to produce blood cells.
Do not consume Oxaliplatin from 1 day before until 1 day after taking Molgramostim. P
Patient concerns
User feedback
What are you using Kinaplat Infusion for?
Cancer of col*
100%
*Cancer of colon and rectum
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1689-90.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 944.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1034-35.
- Oxaliplatin. Hayes, UK: Ranbaxy (UK) Limited a Sun Pharmaceutical Company; 2011 [19 Apr. 2018]. [Accessed 22 Jan. 2019] (online) Available from:
- Oxaliplatin. Bridgewater, New Jersey: sanofi-aventis U.S; 2002 [revised Oct. 2015]. [Accessed 26 Mar. 2019] (online) Available from:
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Cadila Pharmaceuticals Ltd
Address: Sarkhej-Dholka Road, Bhat, Ahmedabad-382 210, INDIA.
Country of origin: India
Lab tests offered by us
Related/Popular tests
48 people viewed this recently₹6041
Inclusive of all taxes
MRP₹6231.55 3% OFF
50.0 ml in 1 bottle
SOLD OUT
Notify me
